Abstract:
The invention provides a TFE polymer capable of providing stretched materials excellent in membrane homogeneity. The present invention is related to a tetrafluoroethylene polymer having stretchability and non-melt-processability and having a standard specific gravity of 2.140 to 2.165, wherein, with regard to the heat-of-fusion curve obtained by subjecting the tetrafluoroethylene polymer in the form of an unbaked polymer to be measured having no history of being heated to a temperature of 300° C. or higher to differential scanning calorimetry at a programming rate of 2° C./minute, the ratio S2/S1 is not lower than 0.90.
Abstract:
A method for treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing is provided. The method includes administration of an effective amount of a compound represented by formula (1):
Abstract:
The present invention relates to diamine compounds which inhibit activated blood coagulation factor X and exhibit an anticoagulant effect and there uses for treating various diseases based on thromboembolism.
Abstract:
Embodiments of the present invention provide a head stack assembly and a manufacturing method thereof in which manufacturing costs as a multi-disc magnetic device are reduced by increasing the yield and reducing inventory of magnetic heads which can be assembled to the head stack assembly. According to one embodiment, a head stack assembly and a manufacturing method thereof includes plural actuator arms to which magnetic heads are assembled through suspensions. The tolerance of the core width or the write element width of the magnetic heads assembled to inside actuator arms of the plural actuator arms is set to be narrower than the tolerance of the core width or the write element width of the magnetic heads assembled to the outside actuator arms.
Abstract:
A method for controlling the different power states of a ClientBlade™ from a remote desktop environment is described. The remote user's (device) connects his computer device (laptop or desktop) to the ClientBlade™ (at the Blade Center) via a Remote Desktop Protocol (RDP), which performs minimal video compression and provides an Ethernet connection back to the Blade Center. The user inputs a pre-defined key sequence, which initiates a power state interface (or input screen). The power state interface allows the user to select one of several power states. Once the power state is selected, a TCP/IP packet is generated and transmitted from the computer device to the ClientBlade™. The packet invokes the selected power state at the ClientBlade™. Once the power state is activated, a completion message verifying the power state change is sent back to the end user's computer device.
Abstract:
A method for controlling the different power states of a ClientBlade™ from a remote desktop environment is described. A remote user is permitted to control the different power states of the ClientBlade™ remotely via a remote client having an operating system or a thin client (or decompression brick) with no operating system. Administered authentication of the remote user is required before access is granted to the management module in the BladeCenter™ environment to enable the changes to the power state of the ClientBlade™.
Abstract:
A compound represented by the general formula (1): Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 (1) wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
Abstract:
A magnet is attached to springs of a sheet cushion. A connecting member is attached to side portions of a seat cushion frame. A magnetic sensor having a magnetic impedance element is fixed on the connecting member while being positioned right below the magnet. By seating of an occupant on the seat cushion, springs are downwardly bent to bring the magnet closer to the magnetic sensor and to thereby change the magnetic field of the magnet detected with the magnetic sensor. The load applied by an occupant to the seat cushion is detected on the basis of the change of the magnetic field.
Abstract:
A compound represented by formula (1): Q1-Q2-To-N(R1)-Q3-N(R2)-T1-Q4 (1) [wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 represents the following group: (wherein Q5 is an alkylene group having 1 to 8 carbon atoms, or the like); and T0 and T1 are carbonyl groups or the like], a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after artificial valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
Abstract:
A steering damper is provided coaxially with a steering shaft, and a handlebar load is provided by causing a variable valve to generate damping force, using rotation of the steering shaft. The damping force is variably controlled in response to vehicle speed. The damping force is fixed to a minimum value C1 for vehicle speeds equal to or below first reference speed V1, fixed to a maximum value C2 for vehicle speeds equal to or above second reference speed V2, and variably controlled in response to vehicle speed and acceleration in an intermediate speed range. Fine maneuverability of a vehicle body is achieved by reducing a load on a handlebar at low vehicle speeds, and a stable movement of the vehicle body is maintained at high vehicle speed by increasing the load on the handlebar and thereby suppressing deflection of the handlebar.